About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Mapk10tm1Flv
targeted mutation 1, Richard A Flavell
MGI:2176237
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Mapk10tm1Flv/Mapk10tm1Flv B6.129S1-Mapk10tm1Flv MGI:3580019
hm2
 		Mapk10tm1Flv/Mapk10tm1Flv involves: 129S1/Sv MGI:3580018
cx3
 		Mapk10tm1Flv/Mapk10tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv 		B6.129S-Mapk9tm1Flv Mapk10tm1Flv MGI:3580020
cx4
 		Mapk10tm1Flv/Mapk10tm1Flv
Mapk8tm1Flv/Mapk8tm1Flv 		involves: 129S1/Sv MGI:3690778
cx5
 		Mapk10tm1Flv/Mapk10tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv 		involves: 129S1/Sv * 129S2/SvPas MGI:3690780


Genotype
MGI:3580019
hm1
Allelic
Composition		 Mapk10tm1Flv/Mapk10tm1Flv
Genetic
Background		 B6.129S1-Mapk10tm1Flv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk10tm1Flv mutation (2 available); any Mapk10 mutation (37 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
behavior/neurological
impaired coordination ( J:87428 )
• improved performance over controls after treatment with MPTP in a rotorod test but only at low speeds

nervous system
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• increased resistance to MPTP induced Parkinson's disease
abnormal somatic motor system morphology ( J:96192 )
• 3 fold improvement in neuron survival in the facial motor nucleus after axotomy (37% survive)
• improved neuron survival in dorsal root ganglia as well

homeostasis/metabolism
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• increased resistance to MPTP induced Parkinson's disease
abnormal dopamine level ( J:87428 )
• reduced dopamine levels but not as much as seen in controls after MPTP treatment

cellular
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• increased resistance to MPTP induced Parkinson's disease




Genotype
MGI:3580018
hm2
Allelic
Composition		 Mapk10tm1Flv/Mapk10tm1Flv
Genetic
Background		 involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk10tm1Flv mutation (2 available); any Mapk10 mutation (37 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
behavior/neurological
decreased susceptibility to pharmacologically induced seizures ( J:43658 )
• resistant to seizures induced by low doses (30mg/kg) of kainic acid
• remain sensitive to pentetrazole induced seizures
• higher doses of kainic acid (45mg/kg)induced seizures similar to those seen in controls but survival was much better, 60% of controls killed by this dose

nervous system
decreased susceptibility to pharmacologically induced seizures ( J:43658 )
• resistant to seizures induced by low doses (30mg/kg) of kainic acid
• remain sensitive to pentetrazole induced seizures
• higher doses of kainic acid (45mg/kg)induced seizures similar to those seen in controls but survival was much better, 60% of controls killed by this dose
decreased neuron apoptosis ( J:124252 )
• lower levels of apoptosis (35%) are induced in primary cortical neuron cultures than in wild-type neurons (55%) after 24 hours of treatment with 25 um Abeta25-35 peptide
• similar results are obtained for treated cultured hippocampal neurons or cortical neurons treated with Abeta 1-40
decreased susceptibility to neuronal excitotoxicity ( J:43658 )
• resistant to damage seen in pyramidal neurons of CA1 of controls when treated with kainic acid
• resistant to hippocampal cell damage which is evident at 30mg/kg kainic acid dose in control mice; limited damage seen at a 45mg/kg dos

cardiovascular system
cardiovascular system phenotype ( J:108253 )
N
• exhibit no difference in response to pressure overload compared to wild-type

cellular
abnormal cell death ( J:117956 )
• in mutants, corticospinal neurons are resistant to lesion-induced cell death whereas ~40% of wild-type CSN die after CSN deafferentation at 4 months of age
decreased neuron apoptosis ( J:124252 )
• lower levels of apoptosis (35%) are induced in primary cortical neuron cultures than in wild-type neurons (55%) after 24 hours of treatment with 25 um Abeta25-35 peptide
• similar results are obtained for treated cultured hippocampal neurons or cortical neurons treated with Abeta 1-40
decreased susceptibility to neuronal excitotoxicity ( J:43658 )
• resistant to damage seen in pyramidal neurons of CA1 of controls when treated with kainic acid
• resistant to hippocampal cell damage which is evident at 30mg/kg kainic acid dose in control mice; limited damage seen at a 45mg/kg dos

homeostasis/metabolism
decreased susceptibility to neuronal excitotoxicity ( J:43658 )
• resistant to damage seen in pyramidal neurons of CA1 of controls when treated with kainic acid
• resistant to hippocampal cell damage which is evident at 30mg/kg kainic acid dose in control mice; limited damage seen at a 45mg/kg dos




Genotype
MGI:3580020
cx3
Allelic
Composition		 Mapk10tm1Flv/Mapk10tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv
Genetic
Background		 B6.129S-Mapk9tm1Flv Mapk10tm1Flv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk10tm1Flv mutation (2 available); any Mapk10 mutation (37 available)
Mapk9tm1Flv mutation (2 available); any Mapk9 mutation (33 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
nervous system
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• resistance to MPTP-induced Parkinson's disease
abnormal somatic motor system morphology ( J:96192 )
• much improved neuron survival in the facial motor nucleus after axotomy (52% survive)

behavior/neurological
behavior/neurological phenotype ( J:87428 )
N
• MPTP treatment had no effect on rotarod performance at any speed

homeostasis/metabolism
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• resistance to MPTP-induced Parkinson's disease
abnormal dopamine level ( J:87428 )
• somewhat reduced dopamine levels after MTP treatment

cellular
decreased susceptibility to dopaminergic neuron neurotoxicity ( J:87428 )
• resistance to MPTP-induced Parkinson's disease




Genotype
MGI:3690778
cx4
Allelic
Composition		 Mapk10tm1Flv/Mapk10tm1Flv
Mapk8tm1Flv/Mapk8tm1Flv
Genetic
Background		 involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk10tm1Flv mutation (2 available); any Mapk10 mutation (37 available)
Mapk8tm1Flv mutation (3 available); any Mapk8 mutation (74 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
nervous system
nervous system phenotype ( J:54653 )
N
• appear healthy and do not exhibit exencephaly or abnormal apoptosis during brain development




Genotype
MGI:3690780
cx5
Allelic
Composition		 Mapk10tm1Flv/Mapk10tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv
Genetic
Background		 involves: 129S1/Sv * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk10tm1Flv mutation (2 available); any Mapk10 mutation (37 available)
Mapk9tm1Flv mutation (2 available); any Mapk9 mutation (33 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
nervous system
nervous system phenotype ( J:54653 )
N
• do not exhibit exencephaly or show abnormal apoptosis during brain development




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory